← Open Payments lookup

KAREN MESKE: Open Payments

NPI 1336600410 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$963 in 32 payments from 11 companies in 2025. Trend: 2023 $247 · 2024 $949 · 2025 $963

Food & beverage: $963
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.4$275
Neurocrine BioSciences, Inc.5$164
Otsuka America Pharmaceutical, Inc.4$94
Teva Pharmaceuticals USA, Inc.4$90
Alkermes, Inc.5$88
Janssen Pharmaceuticals, Inc2$69
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$69
Vanda Pharmaceuticals Inc.2$41
ABBVIE INC.1$34
Takeda Pharmaceuticals U.S.A., Inc.1$20

Products named: COBENFY, INGREZZA, ARISTADA, REXULTI, INVEGA SUSTENNA, CAPLYTA, UZEDY, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.